Prof. Jianbo Zhou | Endocrinology | Best Researcher Award
Director at Civil Aviation General Hospital | China
Prof. Jianbo Zhou is a distinguished clinician-scientist at Beijing Tongren Hospital, Capital Medical University, recognized for his extensive contributions to diabetes epidemiology, metabolic disorders, and their neurological and vascular implications. His scholarly work spans a broad spectrum of influential topics, including landmark contributions such as The Bidirectional Relationship Between Diabetes and Pulmonary Function: Evidence from Observational Studies, where he explores how metabolic dysregulation intersects with respiratory health. He has further advanced the understanding of neuro-metabolic interactions through his highly referenced synthesis, Impact of Antidiabetic Agents on Dementia Risk: A Bayesian Network Meta-Analysis, providing an integrated evaluation of pharmacologic strategies and cognitive outcomes. His expertise in environmental and gestational health is reflected in Air Pollution and Gestational Diabetes Mellitus: Evidence from Cohort Studies, while brain structural alterations in metabolic dysfunction are rigorously presented in Prediabetes and Structural Brain Abnormalities: Evidence from Observational Studies. Dr. Zhou has also contributed pivotal insights into maternal–fetal metabolic interactions through Maternal Diabetes Mellitus and Persistent Pulmonary Hypertension of the Newborn: A Systematic Review and Meta-Analysis. His work on microvascular complications is exemplified by titles such as Could Vitamin D Be Associated With Proliferative Diabetic Retinopathy?, Urine NGAL as an Early Biomarker for Diabetic Kidney Disease, and Plasma Metabolomic Profiling of Proliferative Diabetic Retinopathy, each of which reflects his commitment to precision biomarkers and early disease detection. Through studies like Prediction of Proliferative Diabetic Retinopathy to Asymptomatic Obstructive Coronary Artery Disease in Chinese T2D Individuals and Could Intensive Blood Pressure Control Really Reduce Diabetic Retinopathy Outcomes?, he connects ophthalmic findings with cardiovascular risk and therapeutic strategy. His comprehensive analyses, including Subclinical Hypothyroidism and the Risk of Chronic Kidney Disease in T2D Subjects and Prediction of Risk of Diabetic Retinopathy for All-Cause Mortality, Stroke and Heart Failure, further cement his reputation as a leading voice in linking metabolic dysfunction to multi-organ outcomes. Dr. Zhou’s overarching research interest centers on the complex interaction between metabolism and brain health, supported by his extensive experience in repeated-measure data analysis from longitudinal cohort studies focused on cerebrovascular events, positioning him as an influential thinker shaping the future landscape of endocrine and neurovascular research.
Featured Publications:
Author, A. A., Author, B. B., Author, C. C., & Author, D. D. (2025). Preserved ratio impaired spirometry, airflow obstruction, and their trajectories in relationship to chronic kidney disease: A prospective cohort study. Scientific Reports.
Author, A. A., Author, B. B., Author, C. C., & Author, D. D. (2025). Relationship between dietary inflammatory index and chronic diseases in older U.S. adults: NHANES 1999–2018. BMC Public Health.
Author, A. A., Author, B. B., Author, C. C., Author, D. D., & Author, E. E. (2025). The effect of acylcarnitines on cognitive function: A two-sample Mendelian randomization study. Brain and Behavior.
Author, A. A., Author, B. B., Author, C. C., Author, D. D., & Author, E. E. (2025). Thyroid function and brain structure: Insight from a Mendelian randomization study. Neuroendocrinology.
Author, A. A., Author, B. B., Author, C. C., Author, D. D., Author, E. E., & Author, F. F. (2025). IGF-1R inhibitor IBI311 for the treatment of active thyroid eye disease in Chinese patients: The RESTORE-1 randomized clinical trial. JAMA Ophthalmology.